GlassScriptPhysician profile
Lauren E Moorhead
NPI 1518286319
$1,924.36
in general payments reported to CMS, 2019-2025
31 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $486 · 2020: $91.88 · 2021: $141 · 2022: $328 · 2023: $355 · 2024: $409 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $878.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $878.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $421.74 | 2019-2024 | |
| Olympus America INC. | $206.19 | 2019 | |
| Astellas Pharma US INC | $136.32 | 2024-2025 | Veozah |
| Pfizer INC. | $136.31 | 2022-2024 | |
| Baxter Healthcare | $124.88 | 2021 | |
| Exeltis, USA INC. | $108.87 | 2019-2023 | Slynd |
| Mayne Pharma Commercial LLC | $99.75 | 2023-2024 | |
| Coopersurgical, INC. | $55.83 | 2022-2024 | Wallach Cryosurgical Equipment, Mara Console |
| Organon LLC | $54.30 | 2022-2023 | Nexplanon |
| Sage Therapeutics, LLC | $47.42 | 2024 | |
| Sumitomo Pharma America, INC. | $47.27 | 2023-2024 | Myfembree |
| Hologic Sales and Service, LLC | $39.68 | 2023-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Coolseal Generator, Acessa Provu System |
| Therapeuticsmd, INC. | $39.04 | 2019-2022 | |
| Lilly USA, LLC | $36.69 | 2025 | Zepbound, Mounjaro |
| Minerva Surgical, INC | $36.12 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $35.33 | 2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $32.68 | 2019-2023 | Gardasil 9 |
| Evofem Biosciences, INC. | $32.58 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.11 | 2023 | Cuvitru |
| Csl Behring | $22.72 | 2024 | Hizentra |
| Myovant Sciences INC. | $22.26 | 2022 | |
| Mylan Pharmaceuticals INC. | $20.77 | 2022 | |
| Medtronic, INC. | $18.16 | 2024 | Truclear |
| Bayer Healthcare Pharmaceuticals INC. | $17.99 | 2019 | |
| Allergan, INC. | $16.39 | 2019 | |
| Vertical Pharmaceuticals, LLC | $15.86 | 2019 | |
| Janssen Scientific Affairs, LLC | $15.81 | 2021 | |
| Boston Scientific Corporation | $15.31 | 2019 | |
| Dysis Medical, INC. | $13.64 | 2023 | Dysis Ultra 2.0, Dysis V3 Digital Coploscope, Dysis View |
| Agile Therapeutics, INC. | $12.71 | 2023 | Twirla |
| Lupin INC. | $12.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Moorhead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.